Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties ofN-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2AReceptor Agonist
Anders A. Jensen, John D. McCorvy, Sebastian Leth‐Petersen, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 361, Iss. 3, pp. 441-453
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 213
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30
Molecular insights into psychedelic drug action
Samuel T. Slocum, Jeffrey F. DiBerto, Bryan L. Roth
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 24-38
Open Access | Times Cited: 43
Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics
Deborah Rudin, Matthias E. Liechti, Dino Luethi
Experimental Neurology (2021) Vol. 343, pp. 113778-113778
Open Access | Times Cited: 41
Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats
Kat F. Kiilerich, Joe Lorenz, Malthe B. Scharff, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3829-3841
Open Access | Times Cited: 18
DARK Classics in Chemical Neuroscience: NBOMes
Christian B. M. Poulie, Anders A. Jensen, Adam L. Halberstadt, et al.
ACS Chemical Neuroscience (2019) Vol. 11, Iss. 23, pp. 3860-3869
Open Access | Times Cited: 54
In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5‐HT2AR
Eline Pottie, Christophe P. Stove
Journal of Neurochemistry (2022) Vol. 162, Iss. 1, pp. 39-59
Open Access | Times Cited: 25
A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex
Andrea I. Luppi, Manesh Girn, Fernando Rosas, et al.
Brain (2023) Vol. 147, Iss. 1, pp. 56-80
Open Access | Times Cited: 14
Calcium and Neural Stem Cell Proliferation
Dafne Astrid Díaz-Piña, Nayeli Rivera-Ramírez, Guadalupe García‐López, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4073-4073
Open Access | Times Cited: 5
Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
Tobias Buchborn, Taylor Lyons, Thomas Knöpfel
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 40
The Selective 5HT2A Receptor Agonist, 25CN‐NBOH Exerts Excitatory and Inhibitory Cellular Actions on Mouse Medial Prefrontal Cortical Neurons
Yang Wang, Jesper L. Kristensen, Kristi A. Kohlmeier
Synapse (2025) Vol. 79, Iss. 2
Open Access
Single-dose psychedelic enhances cognitive flexibility and reversal learning in mice weeks after administration
Elizabeth J. Brouns, Tyler G. Ekins, Omar J. Ahmed
Psychedelics. (2025), pp. 1-7
Closed Access
Serotonin Receptor 2A Activation Promotes Evolutionarily Relevant Basal Progenitor Proliferation in the Developing Neocortex
Lei Xing, Nereo Kalebic, Takashi Namba, et al.
Neuron (2020) Vol. 108, Iss. 6, pp. 1113-1129.e6
Open Access | Times Cited: 31
The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation
Anna U. Odland, Lea Jessen, Jesper L. Kristensen, et al.
Neuropharmacology (2019) Vol. 183, pp. 107838-107838
Closed Access | Times Cited: 30
Discovery and Structure–Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists
Emil Märcher-Rørsted, Anders A. Jensen, Gints Šmits, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7224-7244
Open Access | Times Cited: 3
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Clinton E. Canal
Handbook of experimental pharmacology (2018), pp. 227-260
Open Access | Times Cited: 32
In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor
Eline Pottie, Annelies Cannaert, Christophe P. Stove
Archives of Toxicology (2020) Vol. 94, Iss. 10, pp. 3449-3460
Open Access | Times Cited: 27
Structure–Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists
Eline Pottie, Christian B. M. Poulie, Ícaro A. Simon, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 15, pp. 2727-2742
Open Access | Times Cited: 8
Cellular rules underlying psychedelic control of prefrontal pyramidal neurons
Tyler G. Ekins, Isla Brooks, Sameer Kailasa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Acute serotonin 2A receptor activation impairs behavioral flexibility in mice
Dionisio A. Amodeo, Omron Hassan, Landon M. Klein, et al.
Behavioural Brain Research (2020) Vol. 395, pp. 112861-112861
Open Access | Times Cited: 21
The Chronic Treatment With 5-HT2A Receptor Agonists Affects the Behavior and the BDNF System in Mice
А. С. Цыбко, Tatiana V. Ilchibaeva, Elena Filimonova, et al.
Neurochemical Research (2020) Vol. 45, Iss. 12, pp. 3059-3075
Closed Access | Times Cited: 21
Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines
Karolina E. Kolaczynska, Dino Luethi, Daniel Trachsel, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 13
Identification of 5-HT2 Serotonin Receptor Modulators through the Synthesis of a Diverse, Tropane- and Quinuclidine-alkaloid-Inspired Compound Library
Ruwei Yao, Anders A. Jensen, Hogan P. Bryce-Rogers, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11536-11554
Closed Access | Times Cited: 7
Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice
Adam L. Halberstadt, Muhammad Chatha, Stephen J. Chapman, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 3, pp. 406-414
Open Access | Times Cited: 22
The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH
Anders A. Jensen, Adam L. Halberstadt, Emil Märcher-Rørsted, et al.
Biochemical Pharmacology (2020) Vol. 177, pp. 113979-113979
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top